홈 > 시장보고서 > 의약품 > 약물전달

시장보고서

상품코드

1375086

북미 약물전달 시장 예측(-2028년) : 지역별 분석 - 투여 경로별, 유통 채널별, 최종 사용자별

North America Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Route of Administration, Distribution Channel, and End User

발행일: 2023년 08월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 233 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

북미 약물전달 시장은 2023년 9,746억 3,953만 달러에서 2028년에는 1조 4,294억 1,779만 달러로 성장할 것으로 예측됩니다. 2023년부터 2028년까지 CAGR은 8.0%로 추정됩니다.

만성 질환 증가가 북미 약물전달 시장을 견인

미국 질병 예방관리센터(CDC)에 따르면 미국에서는 10명 중 6명이 적어도 하나의 만성 질환을 앓고 있으며, 2019년 시점에서는 10명 중 4명이 2개 이상의 만성 질환을 앓고 있습니다. 만성 질환으로 고통받는 환자는 시간이 지남에 따라 악화되어 환자의 가족과 사회에 큰 부담을 줍니다. 미국암협회(ACS)의 예측에 따르면 미국에서는 2023년에 약 195만 8,310명의 신규암 환자와 60만 9,820명의 사망자를 기록할 가능성이 있습니다. 당뇨병은 생명을 위협하는 만성 질환이며 특효약은 없습니다. 모든 유형의 당뇨병은 신체의 다른 부위에 다양한 합병증을 일으켜 빠른 죽음의 위험을 높입니다. 심장 발작, 뇌졸중, 신부전, 다리 절단, 시력 저하, 신경 손상이 이 질병과 관련된 주요 합병증입니다. 당뇨병의 경우는 세계에서 현저하게 증가하고 있습니다.

만성 질환의 유병률 증가는 지난 수십년동안 약물전달의 집중적인 R&D(R&D)를 촉진했습니다. 만성 질환의 치료에 사용되는 약물의 치료 효과는 나노입자(세라믹, 폴리머, 금속 등), 미셀, 리포좀, 덴드리머와 같은 최적의 약물전달에 의해 향상될 수 있습니다. 약물전달을 이용한 약물의 투여는 또한 약물의 전신적인 부작용을 완화하는데 도움이 됩니다. 당뇨병, 암, 죽상 동맥 경화증, 심근 허혈, 천식, 폐 결핵, 파킨슨병, 알츠하이머병과 같은 다양한 만성 질환에 대해 치료제를 표적화하고 통제하면서 전달하기 위해 다양한 약물전달이 도입되었습니다. 적절한 약물전달은 장기간에 걸쳐 높은 약물 생체이용률을 보장함으로써 모든 약물의 치료 효과를 향상시킵니다. 표적 약물전달(TDDS)은 대상체의 미리 선택된 부위로 제어된 방식으로 약물을 방출합니다. 나노기술을 기반으로 하는 약물전달 시스템은 암 치료에 큰 영향을 주고 있으며, 중합체는 이러한 나노입자 캐리어의 개발에 중요한 역할을 합니다. 투여 경로의 다양성 외에도 나노 치료제 전달(NDDS)의 주목할만한 기술적 이점으로 반감기 연장, 생체 분포 개선, 약물 순환 시간 연장, 약물 방출 제어 및 지속, 세포 간 약물 농도의 상승 등을 들 수 있습니다.

이러한 질병의 만성 특성을 고려하면 만성 질환 환자는 지속적인 약물 치료에 의존하며 부작용의 지속적인 위험과 관련이 있습니다. 표적 약물에 대한 적절한 전달을 개발하면 병원성 병변에서 표적 약물의 축적을 촉진하고 전신 부작용을 줄이고 환자 결과를 개선할 수 있습니다. 따라서 만성 질환과 생활 습관병 증가는 북미 약물전달 시장의 성장을 뒷받침하고 있습니다.

북미 약물전달 시장 개요

북미는 최대 약물전달 시장이며 미국이 최대 시장 점유율을 차지하고 캐나다가 뒤를 잇습니다. 북미 시장 성장의 특징은 바이오제약 및 바이오테크놀로지 기업에 의한 희귀질환 치료제 수요 증가, 주요 시장 진입기업의 존재, 다양한 학술기관 및 연구기관에 의한 광범위한 조사개발입니다. 또한 제약기업과 생명공학기업에 대한 광범위한 조사가 예측기간 동안 북미에서 약물전달 시장의 성장을 지원할 것으로 예상됩니다.

북미 약물전달 시장의 수익과 예측(-2028년)(금액)

북미 약물전달 시장 세분화

북미 약물전달 시장은 투여 경로, 유통 채널, 최종 사용자, 국가별로 구분됩니다.

투여 경로에 따라 주사 약물전달, 경구 약물전달, 점막 약물전달, 국소 약물전달, 이식 약물전달, 안약 전달로 구분됩니다. 2023년 북미 약물전달 시장에서는 주사제 약물전달 분야가 가장 큰 점유율을 차지하고 있습니다.

유통 채널별로는 병원 약국, 소매 약국, 온라인 약국으로 구분됩니다. 2023년 북미 약국 전달 시장에서 병원 약국 부문은 가장 큰 점유율을 차지합니다.

최종 사용자별로는 병원 및 클리닉, 재택치료 현장, 기타 최종 사용자로 구분됩니다. 2023년 북미 약물전달 시장에서는 병원 및 클리닉 부문이 가장 큰 점유율을 차지하고 있습니다.

국가별로는 미국, 캐나다, 멕시코로 구분됩니다. 2023년 북미 약물전달 시장 점유율은 미국이 독점했습니다.

Bausch Health Companies Inc., Baxter International Inc., Becton Dickinson and Co., Boehringer Ingelheim International GmbH, Boston Scientific Corp, Gerresheimer AG, GlaxoSmithKline Plc, Johnson & Johnson, Kindeva Drug Delivery LP, Novartis, Sever Pharma Solutions가 북미 약물전달 시장에서 사업을 전개하는 주요 기업입니다.

시장 성장 촉진요인
- 만성 질환 증가
- 비침습 약물전달에 대한 수요 증가
- 제약회사의 연구개발비 증가
주요 시장 성장 억제요인
- 약물전달 시스템 개발에 따른 고비용
- 약물전달 제품 리콜
주요 시장 기회
- 환자의 컴플라이언스 향상에 주력
향후의 동향
- 전략적 개발과 제품상시
영향 분석

제6장 약물전달 시장 - 북미 분석

북미 약물전달 시장 수익과 예측 분석

제7장 북미 약물전달 시장 : 투여 경로별 수익과 예측(-2028년)

소개
북미 약물전달 시장의 투여 경로별 수익 점유율(2022년, 2028년)
주사 약물전달
경구 약물전달
국소 약물전달
경점막 약물전달
매립형 약물전달
안과용 약물전달

제8장 북미 약물전달 시장 : 유통 채널별 수익과 예측(-2028년)

소개
북미 약물전달 시장의 유통 채널별 수익 점유율(2022년, 2028년)
병원 약국
소매 약국
온라인 약국

제9장 북미 약물전달 시장 : 최종 사용자별 수익과 예측(-2028년)

소개
북미 약물전달 시장의 최종 사용자별 수익 점유율(2022년, 2028년)
병원 및 클리닉
재택치료 현장
기타 최종 사용자

제10장 북미 약물전달 시장 : 국가별 수익과 예측(-2028년)

미국
캐나다
멕시코

제11장 북미 약물전달 시장 : 업계 상황

소개
북미 약물전달 시장 성장 전략
유기적 성장 전략
개요
무기적 성장 전략
개요

제12장 기업 프로파일

Becton Dickinson and Co
Novo Nordisk AS
Boston Scientific Corp
Baxter International Inc
Gerresheimer AG
Kindeva Drug Delivery LP
GlaxoSmithKline Plc
Bausch Health Companies Inc
Boehringer Ingelheim International GmbH
Novartis AG
Sever Pharma Solutions
Johnson & Johnson
Pfizer Inc

제13장 부록

JHS 23.11.17

The North America drug delivery market is expected to grow from US$ 9,74,639.53 million in 2023 to US$ 14,29,417.79 million by 2028. It is estimated to register a CAGR of 8.0% from 2023 to 2028.

Rising Incidence of Chronic Diseases Fuel North America Drug Delivery Market

According to the Centers for Disease Control and Prevention (CDC), ~6 in 10 people in the US suffered from at least one chronic disease, while ~4 in 10 people had two or more chronic diseases as of 2019. Patients suffering from chronic medical conditions deteriorate with time, resulting in an enormous burden on patients' families and society. According to the projections of the American Cancer Society (ACS), the US is likely to record ~1,958,310 new cancer cases and 609,820 deaths in 2023. Diabetes is a life-threatening chronic disease with no specialized cure. All types of diabetes can lead to various complications in different body parts and increase the risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are the major complications associated with this disease. Cases of diabetes have been increasing significantly across the globe.

The increased prevalence of chronic diseases has promoted more intensive research and development (R&D) in drug delivery systems in the past few decades. The therapeutic efficacy of drugs used to treat chronic disease can be improved with optimal drug delivery systems, such as nanoparticles (e.g., ceramic, polymeric, and metallic), micelles, liposomes, and dendrimers. Administration of a drug with a drug delivery system can also help reduce systemic side effects of drugs. Various drug delivery vehicles have been introduced for a targeted and controlled delivery of therapeutics against a wide range of chronic diseases, such as diabetes, cancer, atherosclerosis, myocardial ischemia, asthma, pulmonary tuberculosis, Parkinson's, and Alzheimer's. An appropriate drug delivery system enhances the therapeutic efficacy of any drug by ensuring high drug bioavailability for a long duration. Targeted drug delivery systems (TDDS) release drugs in a controlled manner at a preselected site in a subject's body. Nanotechnology-based delivery systems are making a significant impact on cancer treatment, and polymers play a key role in the development of these nanoparticulate carriers. In addition to the versatility of the administration route, a few of the noteworthy technological advantages of nanotherapeutic drug delivery systems (NDDS) are prolonged half-life, improved biodistribution, increased drug circulation time, controlled and sustained drug release, and elevated intercellular drug concentration.

Given the chronic nature of these conditions, patients with chronic diseases rely on continuous drug treatment, which is associated with an ongoing risk of side effects. Developing appropriate delivery systems for targeted drugs can promote the accumulation of targeted medicines in pathogenic lesions, reduce systemic side effects, and improve patient outcomes. Thus, the increasing incidences of chronic and lifestyle diseases bolster the growth of the North America drug delivery systems market.

North America Drug Delivery Market Overview

North America is the largest market for drug delivery, with the US holding the largest market share, followed by Canada. The market growth in North America is characterized by increased demand for rare disease medications from biopharmaceutical and biotechnology companies, the presence of key market players, and extensive R&D conducted by various academic and research institutes. In addition, extensive research in pharmaceutical and biotechnology companies is expected to support the growth of the drug delivery market in North America during the forecast period.

North America Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)

North America Drug Delivery Market Segmentation

The North America drug delivery market is segmented on the basis of route of administration, distribution channel, end user, and country.

Based on route of administration, the North America drug delivery market is segmented into injectable drug delivery, oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held the largest share of the North America drug delivery market in 2023.

Based on distribution channel, the North America drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the North America drug delivery market in 2023.

Based on end user, the North America drug delivery market is segmented into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment held the largest share of the North America drug delivery market in 2023.

Based on country, the North America drug delivery market is segmented into the US, Canada, and Mexico. The US dominated the share of the North America drug delivery market in 2023.

Bausch Health Companies Inc, Baxter International Inc., Becton Dickinson and Co, Boehringer Ingelheim International GmbH, Boston Scientific Corp, Gerresheimer AG, GlaxoSmithKline Plc, Johnson & Johnson, Kindeva Drug Delivery LP, Novartis AG, Novo Nordisk AS, Pfizer Inc, and Sever Pharma Solutions are the leading companies operating in the North America drug delivery market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America drug delivery market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Drug Delivery Market - by Route of Administration
- 1.3.2 North America Drug Delivery Market - by Distribution Channel
- 1.3.3 North America Drug Delivery Market - by End User
- 1.3.4 North America Drug Delivery Market - by Country

2. North America Drug Delivery Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Drug Delivery Market - Market Landscape

4.1 Overview
4.2 North America PEST Analysis
4.3 Expert's Opinion

5. North America Drug Delivery Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Incidence of Chronic Diseases
- 5.1.2 Growing Demand for Noninvasive Drug Delivery Systems
- 5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
5.2 Key Market Restraints
- 5.2.1 High Cost Associated with Development of Drugs and Delivery Systems
- 5.2.2 Product Recalls in Drug Delivery Systems
5.3 Key Market Opportunities
- 5.3.1 Focus on Improving Patient Compliance
5.4 Future Trends
- 5.4.1 Strategic Developments and Product Launches
5.5 Impact analysis

6. Drug Delivery Market - North America Analysis

6.1 North America Drug Delivery Market Revenue Forecast and Analysis

7. North America Drug Delivery Market - Revenue and Forecast to 2028 - By Route of Administration

7.1 Overview
7.2 North America Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
7.3 Injectable Drug Delivery
- 7.3.1 Overview
- 7.3.2 Injectable Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.3.2.1 Conventional Injection Devices
    - 7.3.2.1.1 Overview
    - 7.3.2.1.2 Conventional Injection Devices: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.3.2.2 Advanced Devices
    - 7.3.2.2.1 Overview
    - 7.3.2.2.2 Advanced Devices: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Oral Drug Delivery
- 7.4.1 Overview
- 7.4.2 Oral Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.4.2.1 Solid Oral Drugs
    - 7.4.2.1.1 Overview
    - 7.4.2.1.2 Solid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.4.2.2 Liquid Oral Drugs
    - 7.4.2.2.1 Overview
    - 7.4.2.2.2 Liquid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.4.2.3 Semi-solid Oral Drugs
    - 7.4.2.3.1 Overview
    - 7.4.2.3.2 Semi-solid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Topical Drug Delivery
- 7.5.1 Overview
- 7.5.2 Topical Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.5.2.1 Semi-solid Topical Drug Delivery
    - 7.5.2.1.1 Overview
    - 7.5.2.1.2 Semi-solid Topical Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.5.2.2 Liquid Topical Drug Delivery Formulations
    - 7.5.2.2.1 Overview
    - 7.5.2.2.2 Liquid Topical Drug Delivery Formulations: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.5.2.3 Solid Topical Drug Delivery Formulations
    - 7.5.2.3.1 Overview
    - 7.5.2.3.2 Solid Topical Drug Delivery Formulations: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.5.2.4 Transdermal
    - 7.5.2.4.1 Overview
    - 7.5.2.4.2 Transdermal Patches: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Transmucosal Drug Delivery
- 7.6.1 Overview
- 7.6.2 Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.6.2.1 Pulmonary and Nasal Drug Delivery
    - 7.6.2.1.1 Overview
    - 7.6.2.1.2 Pulmonary and Nasal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.6.2.2 Buccal and Sublingual Drug Delivery
    - 7.6.2.2.1 Overview
    - 7.6.2.2.2 Buccal and Sublingual Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.6.2.3 Rectal Transmucosal Drug Delivery
    - 7.6.2.3.1 Overview
    - 7.6.2.3.2 Rectal Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.6.2.4 Vaginal Transmucosal Drug Delivery
    - 7.6.2.4.1 Overview
    - 7.6.2.4.2 Vaginal Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Implantable Drug Delivery
- 7.7.1 Overview
- 7.7.2 Implantable Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Ocular Drug Delivery
- 7.8.1 Overview
- 7.8.2 Ocular Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.8.2.1 Eye Drops and Sprays
    - 7.8.2.1.1 Overview
    - 7.8.2.1.2 Eye Drops and Sprays: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.8.2.2 Gels and Ointments
    - 7.8.2.2.1 Overview
    - 7.8.2.2.2 Gels and Ointments: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.8.2.3 Ocular Inserts and Punctal Plugs
    - 7.8.2.3.1 Overview
    - 7.8.2.3.2 Ocular Inserts and Punctal Plugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.8.2.4 Therapeutic Contact Lens
    - 7.8.2.4.1 Overview
    - 7.8.2.4.2 Therapeutic Contact Lens: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Drug Delivery Market - Revenue and Forecast to 2028 - By Distribution Channel

8.1 Overview
8.2 North America Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
8.3 Hospital Pharmacies
- 8.3.1 Overview
- 8.3.2 Hospital Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Retail Pharmacies
- 8.4.1 Overview
- 8.4.2 Retail Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Online Pharmacies
- 8.5.1 Overview
- 8.5.2 Online Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Drug Delivery Market - Revenue and Forecast to 2028 - By End User

9.1 Overview
9.2 North America Drug Delivery Systems Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals and Clinics
- 9.3.1 Overview
- 9.3.2 Hospitals and Clinics: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Home Care Settings
- 9.4.1 Overview
- 9.4.2 Home Care Settings: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Other End User
- 9.5.1 Overview
- 9.5.2 Other End User: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Drug Delivery Market - Revenue and Forecast to 2028 - Country Analysis

10.1 Overview
- 10.1.1 North America Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
  - 10.1.1.1 US: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 US: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 US: North America Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
    - 10.1.1.1.3.1 US: North America Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.1.3.2 US: North America Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.1.3.3 US: North America Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.1.3.4 US: North America Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.1.3.5 US: North America Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.1.4 US: North America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
    - 10.1.1.1.5 US: North America Drug Delivery Market, by End User 2020-2028 (US$ Million)
  - 10.1.1.2 Canada: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 Canada: North America Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
    - 10.1.1.2.3.1 Canada: North America Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.2.3.2 Canada: North America Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.2.3.3 Canada: North America Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.2.3.4 Canada: North America Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.2.3.5 Canada: North America Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.2.4 Canada: North America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
    - 10.1.1.2.5 Canada: North America Drug Delivery Market, by End User 2020-2028 (US$ Million)
  - 10.1.1.3 Mexico: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 Mexico: North America Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
    - 10.1.1.3.3.1 Mexico: North America Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.3.3.2 Mexico: North America Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.3.3.3 Mexico: North America Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.3.3.4 Mexico: North America Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.3.3.5 Mexico: North America Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.3.4 Mexico: North America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
    - 10.1.1.3.5 Mexico: North America Drug Delivery Market, by End User 2020-2028 (US$ Million)

11. North America Drug Delivery Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in North America Drug Delivery Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Becton Dickinson and Co
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Novo Nordisk AS
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Boston Scientific Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Baxter International Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Gerresheimer AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Kindeva Drug Delivery LP
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 GlaxoSmithKline Plc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
  - 12.7.5.1 Key Developments
12.8 Bausch Health Companies Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Boehringer Ingelheim International GmbH
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Novartis AG
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Sever Pharma Solutions
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Johnson & Johnson
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 Pfizer Inc
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.

US $ 3,450

￦ 4,895,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,450

￦ 6,314,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,450

￦ 7,734,000

※ 부가세 별도